MedTech Acquisition Corporation Unit
MTACU
MTACU was delisted on the 10th of August, 2023.
20 hedge funds and large institutions have $35M invested in MedTech Acquisition Corporation Unit in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 10 reducing their positions, and 13 closing their positions.
33% less funds holding
Funds holding: 30 → 20 (-10)
50% less capital invested
Capital invested by funds: $69.7M → $35M (-$34.6M)
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
80% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$3.13M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$11.6K |
| 3 |
Morgan Stanley
New York
|
+$10.1K |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$3.02K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
Hartree Partners
New York
|
-$17.3M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$16.9M |
| 3 |
DM
Deerfield Management
New York
|
-$10M |
| 4 |
IM
Islet Management
New York
|
-$4.93M |
| 5 |
Millennium Management
New York
|
-$1.55M |
MTACU Hedge Fund Activity: Q3 2021 in Review
20 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q3 2021, worth a combined $35M — down 50% from $69.7M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of MTACU and 3 opened new positions — a net loss of 10 holders — while 10 trimmed existing stakes and 2 added.
The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $3.13M. The largest seller was Hartree Partners, exiting entirely with an estimated $17.3M sold.
- 20 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q3 2021, down from 30 in Q2 2021.
- Funds reported $35M of MedTech Acquisition Corporation Unit stock for Q3 2021, down 50% quarter-over-quarter.
- 3 funds opened new MedTech Acquisition Corporation Unit positions in Q3 2021 and 13 closed out, a net change of -10 holders.
- The largest MedTech Acquisition Corporation Unit buyer in Q3 2021 was Gilder Gagnon Howe & Co, an estimated $3.13M added.
- The largest MedTech Acquisition Corporation Unit seller in Q3 2021 was Hartree Partners, an estimated $17.3M sold.
Based on aggregated 13F filings for Q3 2021.